Matches in Wikidata for { <http://www.wikidata.org/entity/Q37624247> ?p ?o ?g. }
- Q37624247 description "article científic" @default.
- Q37624247 description "article scientifique" @default.
- Q37624247 description "articolo scientifico" @default.
- Q37624247 description "artigo científico" @default.
- Q37624247 description "artículu científicu espublizáu en 2015" @default.
- Q37624247 description "bilimsel makale" @default.
- Q37624247 description "scientific article published on December 2015" @default.
- Q37624247 description "vedecký článok" @default.
- Q37624247 description "vetenskaplig artikel" @default.
- Q37624247 description "videnskabelig artikel" @default.
- Q37624247 description "vědecký článek" @default.
- Q37624247 description "wetenschappelijk artikel" @default.
- Q37624247 description "wissenschaftlicher Artikel" @default.
- Q37624247 description "наукова стаття, опублікована в грудні 2015" @default.
- Q37624247 description "научни чланак" @default.
- Q37624247 description "مقالة علمية نشرت في ديسمبر 2015" @default.
- Q37624247 name "Nafamostat Mesilate as an Anticoagulant During Continuous Renal Replacement Therapy in Patients With High Bleeding Risk: A Randomized Clinical Trial" @default.
- Q37624247 name "Nafamostat Mesilate as an Anticoagulant During Continuous Renal Replacement Therapy in Patients With High Bleeding Risk: A Randomized Clinical Trial" @default.
- Q37624247 name "Nafamostat Mesilate as an Anticoagulant During Continuous Renal Replacement Therapy in Patients With High Bleeding Risk: A Randomized Clinical Trial" @default.
- Q37624247 type Item @default.
- Q37624247 label "Nafamostat Mesilate as an Anticoagulant During Continuous Renal Replacement Therapy in Patients With High Bleeding Risk: A Randomized Clinical Trial" @default.
- Q37624247 label "Nafamostat Mesilate as an Anticoagulant During Continuous Renal Replacement Therapy in Patients With High Bleeding Risk: A Randomized Clinical Trial" @default.
- Q37624247 label "Nafamostat Mesilate as an Anticoagulant During Continuous Renal Replacement Therapy in Patients With High Bleeding Risk: A Randomized Clinical Trial" @default.
- Q37624247 prefLabel "Nafamostat Mesilate as an Anticoagulant During Continuous Renal Replacement Therapy in Patients With High Bleeding Risk: A Randomized Clinical Trial" @default.
- Q37624247 prefLabel "Nafamostat Mesilate as an Anticoagulant During Continuous Renal Replacement Therapy in Patients With High Bleeding Risk: A Randomized Clinical Trial" @default.
- Q37624247 prefLabel "Nafamostat Mesilate as an Anticoagulant During Continuous Renal Replacement Therapy in Patients With High Bleeding Risk: A Randomized Clinical Trial" @default.
- Q37624247 P1433 Q37624247-B6E7F40F-7E36-46FF-BF9D-3CA107D01E3E @default.
- Q37624247 P1476 Q37624247-1A4CC510-254A-45D5-AD23-44FB00AF87B4 @default.
- Q37624247 P2093 Q37624247-1D8F06F1-CF0E-4A49-BD4B-418A83DF2020 @default.
- Q37624247 P2093 Q37624247-1E4ED55E-104D-493A-8816-3A0E6D512940 @default.
- Q37624247 P2093 Q37624247-25FCD662-85D7-4BA5-865D-2FE0310B5521 @default.
- Q37624247 P2093 Q37624247-5EEAADF6-A9C1-404B-A9B8-820661187C76 @default.
- Q37624247 P2093 Q37624247-689818E6-D059-4AC1-ABFA-821A96B83C49 @default.
- Q37624247 P2093 Q37624247-B867C5FA-A608-4722-B8C0-CA2EBFB58481 @default.
- Q37624247 P2093 Q37624247-DEC89A09-2138-4BF7-8B0A-0F9E9053F3EF @default.
- Q37624247 P2860 Q37624247-062BFF3F-D03B-4383-BBD0-4083A2E9627D @default.
- Q37624247 P2860 Q37624247-154AC2C8-BE70-4D23-99E6-8291A875331B @default.
- Q37624247 P2860 Q37624247-2702F7A9-4978-4E8E-B48F-60DA975127E2 @default.
- Q37624247 P2860 Q37624247-37DACC87-1FD4-4EA2-9B1A-04AAB81F1AF8 @default.
- Q37624247 P2860 Q37624247-43DA7972-5210-4940-AA9C-C9213F4E8B5B @default.
- Q37624247 P2860 Q37624247-462F990C-EF08-46E0-BE87-2519148A685A @default.
- Q37624247 P2860 Q37624247-6996433D-9DC4-4CD3-80A3-B1CFE6643263 @default.
- Q37624247 P2860 Q37624247-6D869AF6-C1A5-4E0C-B92B-7DB19528F548 @default.
- Q37624247 P2860 Q37624247-72209233-26EF-47AE-8885-B5859C7FDF46 @default.
- Q37624247 P2860 Q37624247-74C83379-3FED-4E92-97FF-E20EECF55C55 @default.
- Q37624247 P2860 Q37624247-83E58FB9-2670-4F4E-8A72-5EA9AD6FE97A @default.
- Q37624247 P2860 Q37624247-89CCA67E-C8A1-4A57-BAE8-7A9E08D6C0BC @default.
- Q37624247 P2860 Q37624247-8CD013BE-E714-4D6C-A83F-73C94122FD84 @default.
- Q37624247 P2860 Q37624247-8CF27992-1501-4937-86F2-C7471522C75F @default.
- Q37624247 P2860 Q37624247-920A4701-D979-4E31-820E-BF3B86803AAA @default.
- Q37624247 P2860 Q37624247-9A7A0B9C-D553-4CA2-A286-94D9EFEB0CD7 @default.
- Q37624247 P2860 Q37624247-ADD250A1-35AB-4306-8042-4A48B0D3F489 @default.
- Q37624247 P2860 Q37624247-B623BAD1-BF4E-4372-B010-A8CF466F551E @default.
- Q37624247 P2860 Q37624247-CC1B1CAF-FC9D-4B44-AE46-41A244E4276E @default.
- Q37624247 P2860 Q37624247-D0FCE596-ECD9-410A-BAAC-6898C626594C @default.
- Q37624247 P2860 Q37624247-D249C2DC-AFA2-44A3-8B57-ED515EFBEB40 @default.
- Q37624247 P2860 Q37624247-D4D4B82A-E5A7-4E04-B35E-B5201BB3B0FB @default.
- Q37624247 P2860 Q37624247-E2E6E73F-0022-4316-A626-5CCFCB32294B @default.
- Q37624247 P2860 Q37624247-EC339B1F-2621-45A7-AD97-A5ED9F28CBD3 @default.
- Q37624247 P2860 Q37624247-EE4F5EB8-6935-42C7-BE06-3F686D6A7250 @default.
- Q37624247 P2860 Q37624247-EFF404C2-C407-424A-BF75-53D3CB64B9F5 @default.
- Q37624247 P2860 Q37624247-F30287E4-85F5-427E-B8BD-A684865EA1D3 @default.
- Q37624247 P2860 Q37624247-F3B4EC23-8DF2-4938-BBD9-2CB4953575CD @default.
- Q37624247 P2860 Q37624247-FA7A05F1-4034-4E49-8780-867D99EF3E6B @default.
- Q37624247 P2860 Q37624247-FCBA3BE4-747E-4B02-A800-BAD53AEB94CD @default.
- Q37624247 P304 Q37624247-9C298EDE-167D-4524-A3A7-12872C1C6079 @default.
- Q37624247 P31 Q37624247-7D465D78-0C20-4D51-9B71-B49E962D80BB @default.
- Q37624247 P356 Q37624247-EB20D0AF-E3A7-487D-8B90-0488A9F0408D @default.
- Q37624247 P407 Q37624247-7D08CF3F-0065-45CB-A871-6C8C42EFF252 @default.
- Q37624247 P433 Q37624247-92975CA7-F31B-4FD8-951A-1128D8125C44 @default.
- Q37624247 P478 Q37624247-32A540F1-54FD-4331-AC03-D03CD9D9E139 @default.
- Q37624247 P50 Q37624247-AB6F64A0-4980-47BF-B7EF-18B46F4F6A62 @default.
- Q37624247 P577 Q37624247-26AA28B9-5BA6-4042-9620-6CF071CBA57A @default.
- Q37624247 P698 Q37624247-00DDCC9D-2601-497C-B1B7-CB68D4170930 @default.
- Q37624247 P921 Q37624247-5639B1E0-C525-48C3-A206-37D925D31618 @default.
- Q37624247 P921 Q37624247-D382E98D-54CF-4B61-A9C4-9A82F47612BA @default.
- Q37624247 P932 Q37624247-D1C4345E-F26F-4AF9-BBBD-3F86927C60B5 @default.
- Q37624247 P356 MD.0000000000002392 @default.
- Q37624247 P698 26717390 @default.
- Q37624247 P1433 Q15716652 @default.
- Q37624247 P1476 "Nafamostat Mesilate as an Anticoagulant During Continuous Renal Replacement Therapy in Patients With High Bleeding Risk: A Randomized Clinical Trial" @default.
- Q37624247 P2093 "Chan-Duck Kim" @default.
- Q37624247 P2093 "Hye Min Jang" @default.
- Q37624247 P2093 "Jang-Hee Cho" @default.
- Q37624247 P2093 "Ji-Young Choi" @default.
- Q37624247 P2093 "Sun-Hee Park" @default.
- Q37624247 P2093 "Yong-Lim Kim" @default.
- Q37624247 P2093 "Yun-Jeong Kang" @default.
- Q37624247 P2860 Q33330478 @default.
- Q37624247 P2860 Q33382598 @default.
- Q37624247 P2860 Q34323157 @default.
- Q37624247 P2860 Q34665432 @default.
- Q37624247 P2860 Q37679631 @default.
- Q37624247 P2860 Q38453284 @default.
- Q37624247 P2860 Q40791079 @default.
- Q37624247 P2860 Q41068305 @default.
- Q37624247 P2860 Q42245295 @default.
- Q37624247 P2860 Q44260805 @default.
- Q37624247 P2860 Q44644452 @default.
- Q37624247 P2860 Q44690172 @default.